Showing results (211-220 of 218) with videos related to
Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 218 results.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397Sarah L Gulliford, Kerwyn Foo, Rachel C Morgan, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 27, 2016
A dosimetric comparison of real-time adaptive and non-adaptive radiotherapy: A multi-institutional study encompassing robotic, gimbaled, multileaf collimator and couch trackingEmma Colvill, Jeremy Booth, Simeon Nill, et al.Magnetic Resonance in Medicine|September 21, 2022
The future of MRI in radiation therapy: Challenges and opportunities for the MR communityRosie J Goodburn, Marielle E P Philippens, Thierry L Lefebvre, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2018
Functional Parameters Derived from Magnetic Resonance Imaging Reflect Vascular Morphology in Preclinical Tumors and in Human Liver MetastasesPavitra Kannan, Warren W Kretzschmar, Helen Winter, et al.Frontiers in Oncology|October 5, 2020
The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive TherapySophie R de Mol van Otterloo, John P Christodouleas, Erwin L A Blezer, et al.International Journal of Radiation Oncology, Biology, Physics|July 15, 2021
Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional RegistrySophie R de Mol van Otterloo, John P Christodouleas, Erwin L A Blezer, et al.Clinical and Translational Radiation Oncology|November 3, 2018
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trialHouda Bahig, Ying Yuan, Abdallah S R Mohamed, et al.Nature Reviews. Clinical Oncology|October 12, 2016
Imaging biomarker roadmap for cancer studiesJames P B O'Connor, Eric O Aboagye, Judith E Adams, et al.Pageof 22